Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000583027 | SCV000689309 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001426470 | SCV001629123 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000583027 | SCV002726535 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-03-05 | criteria provided, single submitter | clinical testing | The c.205+3A>G intronic variant results from an A to G substitution 3 nucleotides after coding exon 2 in the BRIP1 gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |